Harrow Health Inc (HROW) is a Healthcare · Drug Manufacturers - Specialty & Generic company listed on NASDAQ. Price $33.08 (-0.15%), Market cap $1.16B, 52-week low–high $25.74 ~ $54.80.
Harrow, Inc., an eyecare pharmaceutical company, engages in the discovery, development, and commercialization of ophthalmic pharmaceutical products in the United States. It operates through Branded and ImprimisRx segments. The company offers ImprimisRx, an ophthalmology-focused compounded medications. It also provides IHEEZO, a chloroprocaine hydrochloride ophthalmic gel; ophthalmic solutions, including IOPIDINE, VEVYE, and ZERVIATE, as well as BYQLOVI; MAXITROL eye drops; ILEVRO and NEVANAC, a non-steroidal and anti-inflammatory eye drop for pain and inflammation associated with cataract surgery; BYOOVIZ, a LUCENTIS biosimilar indicated for the treatment of patients with Neovascular (Wet) a
Financial statements, price targets, institutional (13F) holdings and related news for Harrow Health Inc are updated in real time on BlackAll Trade.
Harrow Health Inc trades at $33.08 (-0.15%). Real-time quotes and charts are available on BlackAll Trade.
Harrow Health Inc has a market cap of about $1.16B.
Harrow, Inc., an eyecare pharmaceutical company, engages in the discovery, development, and commercialization of ophthalmic pharmaceutical products in the United States. It operates through Branded an